2,4-二氯硫代苯胺 | 2775-38-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2,4-二氯硫代苯胺
• 中文别名: 2,4-二氯苯硫酰胺；2,4-二氯硫代苯甲酰胺
• 英文名称: 2,4-dichlorothiobenzamide
• 英文别名: 2,4-dichlorobenzenecarbothioamide
• CAS: 2775-38-4
• 化学式: C₇H₅Cl₂NS
• mdl: MFCD00173930
• 分子量: 206.095
• InChiKey: WDNBLWURITYPQL-UHFFFAOYSA-N

物化性质

• 熔点：
  135 °C
• 沸点：
  311.5±52.0 °C(Predicted)
• 密度：
  1.473±0.06 g/cm3(Predicted)
• 稳定性/保质期：
  遵照规定使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  58.1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险等级：
  6.1
• 危险品标志：
  Xn
• 危险类别码：
  R36/37/38
• 危险品运输编号：
  UN2811
• 包装等级：
  III
• 危险类别：
  6.1
• 安全说明：
  S26,S37/39
• 储存条件：
  存于阴凉干燥处

SDS

Name:	2 4-Dichlorothiobenzamide 98% Material Safety Data Sheet
Synonym:
CAS:	2775-38-4

Section 1 - Chemical Product MSDS Name:2 4-Dichlorothiobenzamide 98% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
2775-38-4	2,4-Dichlorothiobenzamide	98%	unlisted

Hazard Symbols: XN
Risk Phrases: 22

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful if swallowed.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Keep refrigerated. (Store below 4C/39F.) Store in a tightly closed container. Store in a dry area.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 2775-38-4: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid or liquid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H5Cl2NS
Molecular Weight: 206.09

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 2775-38-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2,4-Dichlorothiobenzamide - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 2775-38-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 2775-38-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 2775-38-4 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2,4-二氯硫代苯胺 在 lithium hydroxide 作用下， 以 乙醇 为溶剂， 反应 4.0h， 生成 2-(2,4-dichlorophenyl)-4-methylthiazole-5-carboxylic acid
  参考文献：
  名称：

  作为 FFA2 激动剂的新型苯基噻唑-甲酰胺酸衍生物的合成、活性和对接研究

  摘要：

  游离脂肪酸受体 2 (FFA2)，也称为 GPR43，由短链脂肪酸 (SCFA) 激活，短链脂肪酸 (SCFA) 主要由肠道微生物群通过未消化的碳水化合物和膳食纤维的发酵产生。FFA2 目前似乎是肥胖、糖尿病、炎症性疾病和癌症管理的潜在目标。在这项研究中，合成了一系列新型苯基噻唑-甲酰胺酸衍生物，并将其作为潜在的正构 FFA2 配体用于结构-活性关系的研究。化合物6E被发现表现出稳定的hFFA2转染的CHO-K1细胞中的强效的双重激动活性（EC 50 = 23.1 μ米）作为阳性对照丙酸（EC 50= 43.3 μ米）。我们还报告了基于 hFFA1 以 2.3 Å 分辨率与 TAK-875 结合的晶体结构的诱变研究结果，以确定诱导 FFA2 激活的正构激动剂6e 的重要残基。

  DOI：

  10.1111/cbdd.12729
• 作为产物：
  描述：

  2,4-二氯苯甲醛肟 在 硫化氢铵 、 trichlorotitanium(IV) trifluoromethanesulfonate 、 1-丁基-3-甲基咪唑溴盐 作用下， 反应 3.2h， 以82%的产率得到2,4-二氯硫代苯胺
  参考文献：
  名称：

  TiCl 3 OTf- [bmim] Br：一种新型有效的催化剂体系，用于从芳基醛肟化学选择性一锅合成硫代酰胺。

  摘要：

  发现TiCl 3 OTf与1-丁基-3-甲基咪唑鎓溴化物的组合是一种高效新颖的催化系统，用于以高产率至优异产率将芳基醛肟化学选择性地一锅转化为相应的硫代酰胺。

  DOI：

  10.1016/j.tetlet.2008.09.084

文献信息

• [EN] ARYL PIPERIDINE DERIVATIVES AND USE THEREOF TO REDUCE ELEVATED LEVELS OF LDL-CHOLESTEROL<br/>[FR] DERIVES D'ARYLE PIPERIDINE ET UTILISATION DE CEUX-CI POUR REDUIRE DES TAUX ELEVES DE LDL-CHOLESTEROL
  申请人：GLAXO GROUP LTD

  公开号：WO2004006924A1

  公开（公告）日：2004-01-22

  This invention relates to novel compounds which up-regulate LDL receptor (LDL-r) expression and to processes for their preparation, pharmaceutical compositions containing them and their medical use. More particularly, this invention relates to novel aromatic piperidines and their use in therapy.

  这项发明涉及一种新型化合物，可以上调LDL受体（LDL-r）的表达，并涉及其制备方法、含有它们的药物组合物以及它们的医疗用途。更具体地说，这项发明涉及新型芳香基哌啶类化合物及其在治疗中的应用。
• A Thiophosphoryl Chloride Assisted Transformation of Arylaldoximes to Thioamides
  作者：Uma Pathak、Lokesh Pandey、Sweta Mathur、M. Suryanarayana

  DOI：10.1055/s-0031-1289994

  日期：2012.2

  Primary benzothioamides were accessed from benzaldoximes (benzaldehyde oximes) via benzonitriles in a sequential tandem approach utilizing thiophosphoryl chloride as a dehydrating and thionating agent. primary thioamides - oximes - thiophosphoryl chloride - nitriles

  使用硫代磷酰氯作为脱水剂和去硫剂，通过苯甲腈通过苯甲腈从苯甲醛肟（苯甲醛肟）中获得伯苯硫酰胺。 伯硫代酰胺-肟-硫代磷酰氯-腈
• Structure–activity relationships of acyloxyamidine cytomegalovirus DNA polymerase inhibitors
  作者：John A. Tucker、Terrance L. Clayton、Connie G. Chidester、Martin W. Schulz、Leigh E. Harrington、Steven J. Conrad、Yoshihiko Yagi、Nancee L. Oien、David Yurek、Ming-Shang Kuo

  DOI：10.1016/s0968-0896(99)00319-3

  日期：2000.3

  initio molecular orbital calculations combined with qualitative estimates of steric interaction energies suggest that the lowest energy conformations of the acyloxyamidine linker are characterized by an extended planar CAr-C=N-O-C arrangement and either a syn-periplanar or anti-periplanar N-O-C-C(Ar') arrangement. Only the anti-periplanar conformation was observed in the crystal structures of three

  本文描述了新型的巨细胞病毒DNA聚合酶抑制剂的结构活性关系，该抑制剂具有两个通过酰氧基oxy连接子连接的芳基。对其中末端基团不同的一系列类似物的研究表明，在先导化合物的2,4-二氯苯基周围有非常窄的SAR，但苯并噻唑环的各种替代物均具有活性。其中最引人注目的是化合物78的异恶唑环，与先导化合物相比，其效价提高了30倍。我们还描述了10个类似物的设计，合成和评估，其中酰氧基am连接基被等位基团修饰或替代。结构-活性关系研究确定了接头-NH2基团是关键的药效学元素。从头算分子轨道计算与对空间相互作用能的定性估计相结合，表明酰氧基am连接子的最低能构象具有扩展的平面CAr-C = NOC排列以及同平面或反平面NOCC（Ar'）安排。在三个酰氧基am的晶体结构中仅观察到反平面构象。在这些研究的基础上设计的最有效的连接基修饰化合物是氨基甲酸20 20，在巨细胞病毒DNA聚合酶抑制试验中，氨基甲酸am的含量约为对照酰氧基am
• [EN] SHMT INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE SHMT ET LEURS UTILISATIONS
  申请人：RAZE THERAPEUTICS INC

  公开号：WO2018106636A1

  公开（公告）日：2018-06-14

  The present invention provides compounds, compositions thereof, and methods of using the same.

  本发明提供了化合物、其组合物以及使用它们的方法。
• [EN] NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMA AGONISTS<br/>[FR] NOUVEAUX COMPOSES 2-ARYLTHIAZOLE UTILISES COMME AGONISTES DES RECEPTEURS PPARALPHA ET PPARGAMMA
  申请人：HOFFMANN LA ROCHE

  公开号：WO2004020420A1

  公开（公告）日：2004-03-11

  The present invention relates to compounds of formula (I) wherein Rl to R10, X, Y and n are as defined in the description and claims, and pharmaceutically acceptable salts and esters thereof. The compounds are useful for the treatment of diseases such as diabetes.

  本发明涉及式(I)的化合物，其中R1至R10、X、Y和n如描述和权利要求中所定义，并且其药学上可接受的盐和酯。这些化合物对于治疗疾病如糖尿病是有用的。